TYMS and non-small cell lung carcinoma: In this study, we have carried out an analysis of prevalence and clinical efficacy of pemetrexed‐based chemotherapy of ROS1 translocation NSCLC patients, and further investigated TS mRNA levels in ROS1‐positive and ROS1‐negative patients.